Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
complement C8 alpha chain | 0.821 | 0.192 | 6.6E-16 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
complement C8 beta chain | 0.760 | 0.269 | 2.3E-19 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1993 | 1993 | ||||||||
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
disease | 0.360 | None | 1.000 | 7 | 0 | 2003 | 2019 | ||||||||
|
hyperpolarization activated cyclic nucleotide gated potassium channel 1 | 0.564 | 0.654 | 1.00 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2 | 0.653 | 0.385 | 0.49 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.160 | None | 0.833 | 6 | 0 | 2006 | 2017 | ||||||||
|
perforin 1 | 0.540 | 0.692 | 5.5E-06 |
|
disease | 0.120 | None | 1.000 | 2 | 0 | 2013 | 2019 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
cytochrome b-245 beta chain | 0.452 | 0.885 | 1.00 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
Bruton tyrosine kinase | 0.464 | 0.808 | 1.00 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 1984 | 1984 | ||||||||
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
disease | 0.100 | None | 1.000 | 31 | 0 | 1999 | 2020 | ||||||||
|
laminin subunit gamma 2 | 0.389 | 0.923 | 2.9E-12 |
|
disease | 0.100 | None | 1.000 | 30 | 0 | 2017 | 2020 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
major histocompatibility complex, class II, DP beta 1 | 0.453 | 0.923 | 5.3E-10 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
major histocompatibility complex, class II, DP alpha 1 | 0.552 | 0.846 | 2.5E-06 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
NLR family CARD domain containing 4 | 0.556 | 0.769 | 9.9E-12 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
C-X-C motif chemokine receptor 4 | 0.362 | 0.923 | 1.8E-02 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
BCL6 transcription repressor | 0.444 | 0.808 | 0.96 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
TANK binding kinase 1 | 0.513 | 0.846 | 7.5E-02 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
B cell linker | 0.603 | 0.731 | 0.61 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
inducible T cell costimulator | 0.502 | 0.731 | 3.1E-02 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
recombination activating 2 | 0.507 | 0.769 | 2.0E-02 |
|
disease | 0.100 | None | 0 | 0 |